Reviewer #2 (Public Review):
Summary:
In this manuscript, the authors combined imaging approaches with molecular and genetic experiments to
(i) for the first time establish a chromatin regulatory role for SDG7;<br /> (ii) examine its role in H3K36 methylation, along with its homolog SDG8;<br /> (iii) examine its potential role in mediating antagonism to PRC2, thereby mediating transcriptional activation.
Strengths:
The manuscript explores interesting and relevant mechanistic hypotheses about chromatin-mediated gene regulation by combining a range of experimental tools and a genome-wide perspective. The writing is very clear. The study makes good connections to existing data and generates datasets that complement existing datasets, providing a valuable resource to the community.
Weaknesses:
Some of the claims appear to need further supporting evidence to establish their robustness.
Review of the main conclusions and supporting evidence:
(1) SDG7 contributes to H3K36 methylation at several loci along with SDG8:<br /> This conclusion is supported by the genome-wide differences (measured by ChIP-seq) in H3K36me3 and me2 levels observed between WT, the sdg7 and sdg8 single mutants, and the double mutant. The reduction in H3K36 methylation levels observed at a large number of genes in the sdg7 mutant, and the further reduction in H3K36 methylation levels in the double mutant compared to sdg8 (observed at multiple genes) indicates that SDG7 promotes this transcription-associated modification. The significantly larger number of H3K36 hypomethylated genes in the double mutant (3380) compared to either of the single mutants (523 and 605) indicates lower overall H3K36me3 levels in the double mutant.<br /> While direct evidence of SDG7 methyltransferase activity on H3K36 is lacking, the study reports structural comparisons using AlphaFold predictions that suggest the possibility of such a role.
(2) SDG7 influences gene expression together with SDG8:<br /> This conclusion is supported by a range of phenotypic differences observed between sdg8 and the double mutant sdg7 sdg8. The reported genome-wide differential gene expression between the WT and the double mutant as well as expression differences in specific genes detected by imaging are also consistent with SDG7 and SDG8 together influencing gene expression. However, a role specifically for SDG7 could be further supported by a direct differential expression analysis between the single mutant sdg8 and the double mutant sdg7 sdg8. A role for SDG7 in gene expression is also consistent with its observed effect on H3K36 methylation, which is generally associated with productive transcription.
(3) SDG8 is exclusively nuclear, but SDG7 localises to the cytosol and the nucleus in meristematic cells:<br /> This conclusion is supported by imaging of fluorescent-tagged SDG8 and SDG7 in the root tip, which shows nuclear localisation of SDG8-GFP, consistent with previous reports, and a combination of nuclear and cytosolic localisation for SDG7-VENUS. However, the study presents only one replicate - more replicates are needed to establish the robustness of this conclusion.
(4) Distinct binding patterns of SDG7 and SDG8 on chromatin:<br /> This conclusion is supported by the analysis of genome-wide binding patterns of these proteins measured by ChIP-seq (using fluorescent tagged versions). This data indicates that while SDG7 tends to localise to TSS and TES regions of genes, SDG8 tends to be more uniformly spread across gene loci. These patterns suggest that SDG7 and SDG8 may influence H3K36 methylation through distinct mechanisms, but do not indicate what these mechanisms may be.
(5) SDG7/SDG8 antagonism with PRC2:<br /> a. SDG7 overlaps with PRC2 and its recruiters on chromatin and can bind to PREs<br /> This conclusion is supported by statistically significant overlaps genome-wide between cis-elements at SDG7 binding peaks and those previously reported to be Polycomb associated. This is further supported by the observation of SDG7 binding peaks close to PRC2 subunit binding peaks at known PRC2 targets.<br /> b. SDG7/SDG8 antagonism with PRC2<br /> This conclusion is supported by the observation that the sdg7 sdg8 double mutant phenotypes are partially rescued by disrupting CLF, one of the PRC2 methyltransferases. However, this does not necessarily suggest a direct antagonism with PRC2, but could be part of a more general antagonism between productive transcription (in which H3K36 methylation plays an active role), and PRC2-mediated silencing.<br /> c. SDG7 can evict PRC2 from PREs to overcome H3K27me3-mediated silencing<br /> This conclusion - that SDG7 directly antagonises PRC2 interaction with cis-elements that mediate its targeting - is partly supported by the observation that inducing overexpression of SDG7 (through dexamethasone induction) can cause changes in CLF occupancy and H3K27me3 levels at certain designated PREs. To establish the robustness of these conclusions, it will be necessary to examine designated regions to be used as a negative control and include a non-transgenic control for the SDG-7-HA ChIP. A suitable negative control may be a non-PRE region known to have a CLF peak and high H3K27me3 levels, where the levels would not be expected to change in this experiment.<br /> It remains to be established whether this apparent antagonism of PRC2 by SDG7 is only part of a more general antagonism of PRC2 by productive transcriptional activity, or whether SDG7 can evict PRC2 from PREs independent of transcripts and therefore is a precursor to switching to an active transcriptional state.<br /> Another aspect that would be interesting to examine in the light of recent findings is the single-cell-level behaviour at these genes targeted by SDG7-to examine whether SDG7 induction is causing individual copies of these genes to stochastically switch to an active transcriptional state so that the observed changes in H3K27me3 result from a fraction of copies completely losing silencing rather than all copies losing some H3K27me3.
(6) H3K36me3 levels are co-regulated by SDG8 and Paf1c, SDG8 associates with Pol II to deliver transcription-coupled H3K36 methylation<br /> This conclusion is supported by analysis of a subset of loci previously reported to be regulated by Paf1c, which also exhibit changes in the sdg7 sdg8 double mutant as well as a clf mutant. This analysis is based on a qualitative examination of ChIP-seq signal at a small number of loci, and therefore provides indirect support for this conclusion. It is, therefore, difficult to draw mechanistic insights from this analysis that go beyond correlation.